Renovaro BiosciencesRENB 
$0.56-9.82%24h
-9.82%24h
Global rank26737
Market cap$31.51M
Change 7d6.26%
YTD Performance-82.22%
SP500 benchmarkUnderperform
P/E-0.79
P/S0
Revenue$0
Earnings-$39.68M
Dividend yield-
Main Sector
Healthcare
Renovaro Biosciences RENB Earnings
Earnings in 2023: $-39.68M
According to Renovaro Biosciences latest financial reports the company had earnings of $-39.68M in 2023-06-30, an decrease of -65.02% to 2022.
Renovaro Biosciences Earnings History from 2020 to 2024
-
Value:-
Renovaro Biosciences Annual Earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 | -$39.68M | -65.02% |
| 2022 | -$113.43M | 324.47% |
| 2021 | -$26.72M | 134.08% |
| 2020 | -$11.42M | - |
View the top earning stocks 
